Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (111-120 of 308) with videos related to

Pageof 31
Sort By:
Thrombosis Research|June 7, 2005
Recombinant FVIIa in children with liver diseaseMaria Pettersson, Björn Fischler, Pia Petrini, et al.
International Journal of Molecular Sciences|November 9, 2024
The Basic Principles of Pathophysiology of Venous ThrombosisSam Schulman, Alexander Makatsariya, Jamilya Khizroeva, et al.
Lancet (London, England)|August 1, 2006
Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysisSimon McRae, Huyen Tran, Sam Schulman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2002
Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapyKristina Koppel, Göran Bratt, Sam Schulman, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective studySiavash Piran, Hugh Traquair, Noel Chan, et al.
The New England Journal of Medicine|October 31, 2003
Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatranSam Schulman, Karin Wåhlander, Torbjörn Lundström, et al.
Blood|March 21, 2002
Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?Johanna S Ungerstedt, Sam Schulman, Nils Egberg, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 20, 2012
Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation: a meta-analysis?Fareeha Qayyum, Anne Holbrook, Jason Lam, et al.
Circulation. Cardiovascular Quality and Outcomes|October 7, 2010
Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trialsMenno V Huisman, Daniel J Quinlan, Ola E Dahl, et al.
Thrombosis and Haemostasis|January 18, 2006
Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VIISam Schulman, Geir E Tjønnfjord, Richard Wallensten, et al.
Pageof 31

Showing results (111-120 of 308) with videos related to

Sort By:
Pageof 31
Thrombosis Research|June 7, 2005
Recombinant FVIIa in children with liver diseaseMaria Pettersson, Björn Fischler, Pia Petrini, et al.
International Journal of Molecular Sciences|November 9, 2024
The Basic Principles of Pathophysiology of Venous ThrombosisSam Schulman, Alexander Makatsariya, Jamilya Khizroeva, et al.
Lancet (London, England)|August 1, 2006
Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysisSimon McRae, Huyen Tran, Sam Schulman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2002
Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapyKristina Koppel, Göran Bratt, Sam Schulman, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective studySiavash Piran, Hugh Traquair, Noel Chan, et al.
The New England Journal of Medicine|October 31, 2003
Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatranSam Schulman, Karin Wåhlander, Torbjörn Lundström, et al.
Blood|March 21, 2002
Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?Johanna S Ungerstedt, Sam Schulman, Nils Egberg, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 20, 2012
Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation: a meta-analysis?Fareeha Qayyum, Anne Holbrook, Jason Lam, et al.
Circulation. Cardiovascular Quality and Outcomes|October 7, 2010
Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trialsMenno V Huisman, Daniel J Quinlan, Ola E Dahl, et al.
Thrombosis and Haemostasis|January 18, 2006
Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VIISam Schulman, Geir E Tjønnfjord, Richard Wallensten, et al.
Pageof 31